| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-21956-50ul | |||
MAB002, open histogram), followed by Phycoerythrin-conjugated Anti-Mouse IgG F(ab')2Secondary Antibody (Catalog # F0102B)." alt="Human blood-derived granulocytes were stained with Mouse Anti-Human FCAR/CD89 Monoclonal Antibody (Catalog # MAB3939, filled histogram) or isotype control antibody (Catalog # MAB002, open histogram), followed by Phycoerythrin-conjugated Anti-Mouse IgG F(ab')2Secondary Antibody (Catalog # F0102B)." class="big_thumb" />
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | MAB3939-SP | |||
| Carrier Free | FAB3939V-100UG | |||
| Carrier Free | FAB3939U-100UG | |||
| Carrier Free | FAB3939T-100UG | |||
| Carrier Free | FAB3939S-100UG | |||
| Carrier Free | FAB3939R-100UG | |||
| Carrier Free | FAB3939N-100UG | |||
| Carrier Free | FAB3939G-100UG | |||
5-001-A, open histogram), followed by NorthernLights™ 557-conjugated Anti-Sheep IgG Secondary Antibody (Catalog # NL010)." alt="Human whole blood monocytes and granulocytes were stained with Sheep Anti-Human FCAR/CD89 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF3939, filled histogram) or isotype control antibody (Catalog # 5-001-A, open histogram), followed by NorthernLights™ 557-conjugated Anti-Sheep IgG Secondary Antibody (Catalog # NL010)." class="big_thumb" />
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | AF3939-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB100-63266-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-20161-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-89483-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-89482-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-90841-50ul | |||
![Western Blot: FCAR/CD89 Antibody (SR2145) [NBP3-21956] - Western blot analysis using NBP3-21956 in HL-60 cell lysate.](http://images.novusbio.com/fullsize/nbp3-21956_rabbit-fcar-cd89-mab-sr2145-672023106235.jpg "Western Blot: FCAR/CD89 Antibody (SR2145) [NBP3-21956] - Western blot analysis using NBP3-21956 in HL-60 cell lysate.")
MAB002) followed by Allophycocyanin-conjugated Anti-Mouse IgG Secondary Antibody (Catalog # ![Flow Cytometry: FCAR/CD89 Antibody (MIP8a) [NB100-63266] - Staining of peripheral blood granulocytes using CD89 PE.](http://images.novusbio.com/fullsize/FCAR-CD89-Antibody-MIP8a-Flow-Cytometry-NB100-63266-img0001.jpg "Flow Cytometry: FCAR/CD89 Antibody (MIP8a) [NB100-63266] - Staining of peripheral blood granulocytes using CD89 PE.")
![Western Blot: CD89 Antibody [NBP2-15820] - Sample (30 ug of whole cell lysate) A: Raji B: K562 5% SDS PAGE gel, diluted at 1:1000.](http://images.novusbio.com/fullsize/CD89-Antibody-Western-Blot-NBP2-15820-img0001.jpg "Western Blot: CD89 Antibody [NBP2-15820] - Sample (30 ug of whole cell lysate) A: Raji B: K562 5% SDS PAGE gel, diluted at 1:1000.")
![Immunohistochemistry-Paraffin: FCAR/CD89 Antibody [NBP2-15820] - Staining at cytoplasm in human cervical carcinoma.](http://images.novusbio.com/fullsize/FCAR-CD89-Antibody-Immunohistochemistry-Paraffin-NBP2-15820-img0003.jpg)
![Flow Cytometry: Mouse Monoclonal FCAR/CD89 Antibody (A59) [NBP3-09118] - Flow cytometry surface staining pattern of human peripheral whole blood stained using anti-human CD89 (A59) purified antibody (concentration in sample 3 ug/ml) GAM APC.](http://images.novusbio.com/fullsize/antibody/nbp3-09118_mouse-monoclonal-fcar-cd89-antibody-a59-flow-cytometry-12122024144628..jpg "Flow Cytometry: Mouse Monoclonal FCAR/CD89 Antibody (A59) [NBP3-09118] - Flow cytometry surface staining pattern of human peripheral whole blood stained using anti-human CD89 (A59) purified antibody (concentration in sample 3 ug/ml) GAM APC.")
![Flow Cytometry: Mouse Monoclonal FCAR/CD89 Antibody (A59) [NBP3-09118] - Separation of human neutrophil granulocytes (red-filled) from CD89 negative lymphocytes (black-dashed) in flow cytometry analysis (surface staining) of human peripheral whole blood stained using anti-human CD89 (A59) purified antibody (concentration in sample 3 ug/ml) GAM APC.](http://images.novusbio.com/fullsize/antibody/nbp3-09118_mouse-monoclonal-fcar-cd89-antibody-a59-flow-cytometry-12122024144152..jpg)
![Flow Cytometry: FCAR/CD89 Antibody (14A8 (14.1)) - Chimeric - Azide and BSA Free [NBP3-20161] - Paraformaldehyde fixed human peripheral blood monocytes permeabilized with 0.5% Triton were stained with anti-unknown specificity antibody (isotype control, black line) or the rabbit IgG version of 14A8 (14.1) (NBP3-20161, blue line) at a dilution of 1:100 for 1h at RT. After washing, the bound antibody was detected using a goat anti-rabbit IgG AlexaFluor(R) 488 antibody at a dilution of 1:1000 and cells analyzed using a FACSCanto flow-cytometer.](http://images.novusbio.com/fullsize/nbp3-20161_rabbit-fcar-cd89-mab-14a8-14-1-chimeric-azide-bsa-free-2742023924255.png "Flow Cytometry: FCAR/CD89 Antibody (14A8 (14.1)) - Chimeric - Azide and BSA Free [NBP3-20161] - Paraformaldehyde fixed human peripheral blood monocytes permeabilized with 0.5% Triton were stained with anti-unknown specificity antibody (isotype control, black line) or the rabbit IgG version of 14A8 (14.1) (NBP3-20161, blue line) at a dilution of 1:100 for 1h at RT. After washing, the bound antibody was detected using a goat anti-rabbit IgG AlexaFluor(R) 488 antibody at a dilution of 1:1000 and cells analyzed using a FACSCanto flow-cytometer.")
